Where does plasma methylglyoxal originate from?

Diabetes Research and Clinical Practice

Volumn 99, Issue 3, 2013, Pages 260-271

  Kalapos, Miklós Péter ^a  

^a Theoretical Biology Research Group Budapest   (Hungary)

Author keywords

Aminoacetone; Blood vessels; Methylglyoxal; Red blood cells; S d lactoylglutathione

Indexed keywords

1,2 DICARBONYL; 3 HYDROXYBUTYRIC ACID; ACETONE; AMINOACETONE; CARBONYL DERIVATIVE; GLUCOSE; GLYOXALASE; HEMOGLOBIN A1C; INSULIN LISPRO; KETONE BODY; METHYLGLYOXAL; PIG INSULIN; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; AMINOACETONE BLOOD LEVEL; BLOOD LEVEL; CARBOHYDRATE METABOLISM; CATALYSIS; CELL DAMAGE; DEGRADATION; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; GLYCOLYSIS; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KETONE BODY BLOOD LEVEL; LIPID METABOLISM; METHYLGLYOXAL BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATIENT MONITORING; POSTPRANDIAL STATE; PROTEIN GLYCOSYLATION; RETROSPECTIVE STUDY; REVIEW;

ACETONE; DIABETES MELLITUS; ERYTHROCYTES; HUMANS; PYRUVALDEHYDE; RETROSPECTIVE STUDIES;

EID: 84876181371     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.11.003     Document Type: Review

References (76)

1. Whiting D.R., Guariguata L., Weil C., Shaw J. IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321.
2. Roglic G., Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract 2010, 87:15-19.
3. c targets. Int J Clin Pract 2006, 60:1138-1145.
4. Kalapos M.P. The tandem of free radicals and methylglyoxal. Chem Biol Interact 2008, 171:251-271.
5. Thornalley P.J. The glyoxalase system in health and disease. Mol Asp Med 1993, 14:287-371.
6. Nemet I., Varga-Defterdarovic L., Turk Z. Methylglyoxal in food and living organisms. Mol Nutr Food Res 2006, 50:1105-1117.
7. Thornalley P.J. Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochem J 1988, 254:751-755.
8. Martins AMTBS, Cordeiro C.A.A., Ponces Freire A.M.J. In situ analysis of methylglyoxal metabolism in Saccharomyces cerevisiae. FEBS Lett 2001, 499:41-44.
9. Wang J., Chang T. Methylglyoxal content in drinking coffee as a cytotoxic factor. J Food Sci 2010, 75:H167-H171.
10. Kalapos M.P. Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications. Toxicol Lett 1999, 110:145-175.
11. Shibamoto T. Analytical methods for trace levels of reactive carbonyl compounds in lipid peroxidation systems. J Pharmaceut Biomed Anal 2006, 41:12-25.
12. Vander Jagt D.L. The glyoxalase system. Glutathione: chemical, biochemical and medical aspects - part A 1989, 597-641. John Wiley and Sons, Inc., New York. D. Dolphin, R. Poulson, O. Avramovic (Eds.).
13. Vander Jagt D.L., Hassenbrook R.K., Hunsaker L.A., Brown W.M., Royer R.E. Metabolism of the 2-oxoaldehyde methylglyoxal by aldose reductase and by glyoxalase - I: roles for glutathione in both enzymes and implications for diabetic complications. Chem Biol Interact 2001, 130-132:549-562.
14. Beisswenger P.J., Howell S.K., Touchette A.D., Lal S., Szwergold B.S. Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes 1999, 48:198-202.
15. Odani H., Shinzato T., Matsumoto Y., Usami J., Maeda K. Increase in three α,β-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction. Biochem Biophys Res Commun 1999, 236:89-93.
16. Beisswenger P.J., Howell S.K., O'Dell R.M., Wood M.E., Touchette A.D., Szwergold B.S. α-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diabetes Care 2001, 24:726-732.
17. Lapolla A., Flamini R., Vedova A.D., Senezi A., Reitano R., Fedele D., et al. Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. Clin Chem Lab Med 2003, 41:1166-1173.
18. Lapolla A., Reitano R., Seraglia R., Sartore G., Ragazzi E., Traidi P. Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress. Mol Nutr Food Res 2005, 49:685-690.
19. Nemet I., Turk Z., Duvnjak L., Car N., Varga-Defterdarovic L. Humoral methylglyoxal levels reflects glycemic fluctuation. Clin Biochem 2005, 38:379-383.
20. Turk Z., Nemet I., Varga-Defterdarovic L., Car N. Elevated level of methylglyoxal during diabetic ketoacidosis and its recovery phase. Diab Metabol 2006, 32:176-180.
21. Nicolay J.P., Schneider J., Niemoeller O.M., Artunc F., Portero-Otin M., Haik G., et al. Stimulation of suicidal erythrocyte death by methyglyoxal. Cell Physiol Biochem 2006, 18:223-232.
22. Wang H., Meng Q.H., Gordon J.R., Khandwala H., Wu L. Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus. Clin Biochem 2007, 40:1232-1239.
23. Han Y., Randell E., Vasdev S., Gill V., Gadag V., Newhook L.A., et al. Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with type 1 diabetes. Mol Cell Biochem 2007, 305:123-131.
24. Kandhro A.J., Mirza M.A., Khuhawar M.Y. Capillary gas chromatographic determination of methylglyoxal from serum of diabetic patients by precolumn derivatization using meso-stilbenediamine as derivatizing reagent. J Chromatogr Sci 2008, 46:539-543.
25. Ogawa S., Nakayama K., Nakayama M., Mori T., Matsushima M., Okamura M., et al. Methylglyoxal is a predictor in type 2 diabetic patients of intima-media thickening and elevation of blood pressure. Hypertension 2010, 56:471-476.
26. Lu J., Randell E., Han Y.C., Adeli K., Krahn J., Meng Q.H. Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy. Clin Biochem 2011, 44:307-311.
27. Lu J., Zello G.A., Randell E., Adeli K., Krahn J., Meng Q.H. Closing the anion gap: contribution of d-lactate to diabetic ketoacidosis. Clin Chim Acta 2011, 412:286-291.
28. Thornalley P.J., Hooper N.I., Jennings P.E., Florkowski C.M., Jones A.F., Lunec J., et al. The human red blood cell glyoxalase system in diabetes mellitus. Diab Res Clin Pract 1989, 7:115-120.
29. McLellan A.C., Phillips S.A., Thornalley P.J. The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene. Anal Biochem 1992, 206:17-23.
30. McLellan A.C., Thornalley P.J., Benn J., Sonksen P.H. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci 1994, 87:21-29.
31. Dhar A., Desai K., Liu J., Wu L. Methylglyoxal, protein binding and biological samples: are we getting the true measure?. J Chromatogr B 2009, 877:1093-1100.
32. Thornalley P.J. Advances in glyoxalase research. Glyoxalase expression in malignancy, anti-proliferative effects of methylgloyxla, glyoxalase I inhibitor diesters and S-d-lactoylglutathione, and methylglyoxal-modified protein binding and endocytosis by the advanced glycation endproduct receptor. Crit Rev Oncol/Hemat 1995, 20:99-128.
33. Obata T. Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review. Life Sci 2006, 79:417-422.
34. Kazachkov M., Yu P.H. A novel HPLC procedure for detection and quantification of aminoacetone, a precursor for methylglyoxal, in biological samples. J Chromatogr B 2005, 824:116-122.
35. Thornalley P.J., Langborg A., Minhas H.S. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 1999, 344:109-116.
36. Goh S.-Y., Cooper M.E. The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008, 93:1143-1152.
37. Thornalley P.J. Advanced glycation and the development of diabetic complications. Unifying the involvement of glucose, methylglyoxal and oxidative stress. Endocrinol Metab 1996, 3:149-166.
38. Mentink C.J.A.L., Kilhovd B.K., Rondas-Colbers G.J.W.M., Torjesen P.A., Wolffenbuttel BH-R Time course of specific AGEs during optimised glycaemic control in type 2 diabetes. Netherlands J Med 2005, 64:10-16.
39. Ahmed N., Babaei-Jadidi R., Howell S.K., Thornalley P.J., Beisswenger P.J. Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. Diabetes Care 2005, 28:2465-2471.
40. Owen O.E., Trapp V.E., Skutches C.L., Mozzoli M.A., Hoeldtke R.D., Boden G. Acetone metabolism during diabetic ketoacidosis. Diabetes 1982, 31:242-248.
41. Reichard G.A., Skutches C.I., Hoeldtke R.D. Acetone metabolism in humans during diabetic ketoacidosis. Diabetes 1986, 35:668-674.
42. Beisswenger B.G.K., Delucia E.M., Lapoint N., Sanford R.J., Beisswenger P.J. Ketosis leads to increased methylglyoxal production on the Atkins diet. Ann NY Acad Sci 2005, 1043:201-210.
43. Valentine W.N. Metabolism of human erythrocytes. Studies in health and disease. Arch Int Med 1975, 135:1307-1313.
44. 1H NMR and a computer modelling. Eur J Biochem 1990, 193:83-90.
45. Taylor R., Agius L. The biochemistry of diabetes. Biochem J 1988, 250:625-640.
46. Vander Jagt D.L., Robinson B., Taylor K.K., Hunsaker L. Reduction of trioses by NADPH-dependent aldo-keto-reductases. J Biol Chem 1992, 267:4364-4369.
47. Sakhi A.K., Berg T.J. Reduced glutathione concentrations are not decreased in red blood cells of patients with long term type 1-diabetes. Scand J Clin Lab Invest 2010, 71:108-111.
48. Thornalley P.J., Jahan I., Ng R. Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycemia by thiamine in vitro. J Biochem 2001, 129:543-549.
49. Beisswenger P.J., Howell S.K., Smith K., Szwergold B.S. Glyceraldehyde-3-phosphate dehydrogenase activity is an independent modifier of methylglyoxal levels in diabetes. Biochim Biophys Acta 2003, 1637:98-106.
50. Phillips S.A., Thornalley P.J. The formation of methylglyoxal from triose phosphates. Eur J Biochem 1993, 212:101-105.
51. Beisswenger P.J., Howell S.K., Nelson R.G., Mauer M., Szwergold B.S. α-Oxoaldehyde metabolism and diabetic complications. Biochem Soc Trans 2003, 31:1358-1363.
52. Beisswenger P.J., Drummond K.S., Nelson R.G., Howell S.K., Szwergold B.S., Mauer M. Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes 2005, 54:3274-3281.
53. Karg E., Papp F., Tassi N., Janáky T., Wittman Gy, Túri S. Enhanced methylglyoxal formation in erythrocytes of hemodialyzed patients. Metabolism 2009, 58:976-982.
54. Miyata T., van Ypersele de Strihou C., Imasawa T., Yoshino A., Ueda Y., Ogura H., et al. Deficiency is associated with an unusual level of advanced glycation end products in a hemolysis patient. Kidney Int 2001, 60:2351-2359.
55. Wu L. The pro-oxidant role of methylglyoxal in mesenteric artery smooth muscle cells. Can J Physiol Pharmacol 2005, 83:63-68.
56. Gonzalez F.J., Lee Y.-H. Constitutive expression of hepatic cytochrome P450 genes. FASEB J 1996, 10:1112-1117.
57. Song B.J., Veech R.L., Saenger P. Cytochrome P450IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics. J Clin Endocrinol Metab 1990, 71:1036-1040.
58. Brouwers O., Niessen P.M., Haenen G., Miyata T., Brownlee M., Stehouwer C.D., et al. Hyperglycemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia 2010, 53:989-1000.
59. Matsumoto A., Kim K.-R., Oshima G., Kunimoto M., Okawa K., Iwamatsu A., et al. Glyoxalase I is a novel nitric-oxide-responsive protein. Biochem J 1999, 344:837-844.
60. Sankaralingam S., Xu H., Jiang Y., Sawamura T., Davidge S.T. Evidence for increased methylglyoxal in the vasculature of women with preeclampsia. Role of upregulation of LOX-1 and arginase. Hypertension 2009, 54:897-904.
61. Kalapos M.P., Desai K M., Wu L. Methylglyoxal, oxidative stress, and aging. Aging and aging related disorders 2010, 149-167. Springer Science+Busiess Media, LLC, New York. S. Bondy, K. Maiese (Eds.).
62. Musa-Veloso K. Non-invasive detection of ketosis and its application in refractory epilepsy. Prostagl Leukotr Ess Fatty Acids 2004, 70:329-335.
63. Che W., Asahi M., Takahashi M., Kaneto H., Okado A., Higashiyama S., et al. Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. The involvement of reactive oxygen species formation and a possible implication for atherogenesis in diabetes. J Biol Chem 1997, 272:18453-18459.
64. Riboulet-Chavey A., Pierron A., Durand I., Murdaca J., Giudicelli J., van Obberghen E. Methylglyoxal impairs the insulin signaling pathways independently of the formation of intracellular reactive oxygen species. Diabetes 2006, 55:1289-1299.
65. Chaplen F.W.R., Fahl W.E., Cameron D.C. Method for determination of free intracellular and extracellular methylglyoxal in animal cells grown in culture. Anal Biochem 1996, 238:171-178.
66. Dobler D., Ahmed N., Song L., Eboigbodin K.E., Thornalley P.J. Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes 2006, 55:1961-1969.
67. α-acetyl-lysine, and bovine serum albumin. J Biol Chem 1994, 269:32299-32305.
68. Chaplen F.W.R., Fahl W.E., Cameron D.C. Evidence of high levels of methylglyoxal in cultured Chinese hamster ovary cells. Proc Nat Acad Sci U S A 1998, 95:5333-5338.
69. Nemet I., Varga-Defterdarovic L., Turk Z. Preparation and quantification of methylglyoxal in human plasma using reverse-phase high-performance liquid chromatography. Clin Chem 2004, 37:875-881.
70. Phillips S.A., Mirrlees D., Thornalley P.J. Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Biochem Pharmacol 1993, 46:805-811.
71. Randell E.W., Vasdev S., Gill V. Measurement of methylglyoxal in rat tissues by electrospray ionization mass spectrometry and liquid chromatography. J Pharmacol Toxicol Meth 2005, 51:153-157.
72. Beutler E. Drug-induced hemolytic anemia. Pharmacol Rev 1969, 21:73-103.
73. Ahmed N., Battah S., Karachalis N., Babael-Jajidi R., Horányi M., Baróti K., et al. Increased formation of methylglyoxal and protein glycation, oxidation and nitrosation in triosephosphate isomerase deficiency. Biochim Biophys Acta 2003, 1639:121-132.
74. Virtue M.A., Furne J.K., Nuttall F.Q., Lewitt M.D. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 2004, 27:931-935.
75. Shinohara M., Thornalley P.J., Giardino I., Beisswenger P., Thorpe S.R., Onorato J., et al. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 1998, 101:1142-1147.
76. e{open}-(Carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 1997, 324:565-570.